Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Robert Baffi. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Robert Baffi har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:CPMV / Mosaic ImmunoEngineering, Inc. | Director | |
US:BMRN / BioMarin Pharmaceutical Inc. | President, Global Mfg/Tech Ops | 117 138 |
US:KBIO / KaloBios Pharmaceuticals, Inc. | Director | 5 000 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Robert Baffi. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp CPMV / Mosaic ImmunoEngineering, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i CPMV / Mosaic ImmunoEngineering, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel CPMV / Mosaic ImmunoEngineering, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i CPMV / Mosaic ImmunoEngineering, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Robert Baffi som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-02-22 |
|
4 | CPMV |
Mosaic ImmunoEngineering Inc.
Convertible Note |
J - Other | 50 000,00 | ||||||
2020-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 501 | 117 138 | −2,90 | 73,05 | −255 748 | 8 556 931 | |
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 30 390 | 30 390 | |||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 660 | 120 639 | 9,69 | ||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −7 600 | 109 979 | −6,46 | 84,50 | −642 200 | 9 293 226 | |
2020-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 852 | 117 579 | 9,15 | ||||
2019-06-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 309 | 107 727 | 0,29 | 68,78 | 21 254 | 7 409 679 | |
2019-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 14 160 | 107 418 | 15,18 | ||||
2019-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 501 | 93 258 | −3,62 | 88,05 | −308 263 | 8 211 367 | |
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 24 120 | 24 120 | |||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 630 | 96 759 | 11,05 | ||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −7 083 | 87 129 | −7,52 | 94,53 | −669 556 | 8 236 304 | |
2019-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −917 | 94 212 | −0,96 | 94,76 | −86 895 | 8 927 529 | |
2019-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 853 | 95 129 | 14,23 | ||||
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 173 | 71 882 | −6,71 | 105,00 | −543 165 | 7 547 610 |
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −6 949 | 0 | −100,00 | |||
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −328 | 83 276 | −0,39 | 99,01 | −32 475 | 8 245 157 |
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −6 621 | 83 604 | −7,34 | 99,00 | −655 479 | 8 276 796 |
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 6 949 | 90 225 | 8,34 | 14,39 | 99 996 | 1 298 338 |
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 562 | 83 276 | −1,84 | 92,07 | −143 813 | 7 667 221 | |
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 309 | 84 838 | 0,37 | 68,78 | 21 254 | 5 835 327 | |
2018-04-27 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 500 | 84 445 | −3,98 | 81,36 | −284 760 | 6 870 445 | |
2018-04-26 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 274 | 81 168 | 17,82 | ||||
2018-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 486 | 84 459 | −3,96 | 81,36 | −283 621 | 6 871 584 | |
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 38 760 | 38 760 | |||||
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 120 | 87 945 | 15,98 | ||||
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 644 | 75 825 | −4,59 | 83,57 | −304 529 | 6 336 695 | |
2018-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 615 | 79 469 | −1,99 | 79,86 | −128 974 | 6 346 394 | |
2018-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 190 | 81 084 | 17,69 | ||||
2017-10-13 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
J - Other | 0 | 72 102 | 0,00 | ||||
2017-10-13 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
J - Other | 0 | 82 963 | 0,00 | ||||
2017-10-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 915 | 28 761 | −9,20 | 92,06 | −268 355 | 2 647 738 |
2017-10-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 500 | 129 083 | −10,72 | 92,50 | −1 433 676 | 11 939 558 |
2017-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 644 | 144 583 | −1,12 | 90,72 | −149 144 | 13 116 570 | |
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 566 | 146 227 | −1,06 | 91,50 | −143 289 | 13 379 770 | |
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 302 | 147 793 | 0,20 | 70,30 | 21 232 | 10 390 439 | |
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 38 420 | 38 420 | |||||
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 870 | 147 491 | 8,75 | ||||
2017-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 289 | 135 621 | −2,37 | 92,50 | −304 232 | 12 544 942 | |
2017-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 749 | 138 910 | −1,24 | 93,95 | −164 319 | 13 050 594 | |
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 917 | 140 659 | 9,26 | ||||
2016-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 644 | 128 742 | −1,26 | 90,00 | −147 960 | 11 586 780 | |
2016-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 000 | 130 386 | −3,69 | 87,05 | −435 248 | 11 350 062 | |
2016-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 566 | 135 386 | −1,14 | 82,71 | −129 524 | 11 197 776 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 088 | 136 952 | −1,50 | 80,80 | −168 710 | 11 065 722 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 414 | 139 040 | 0,30 | 51,26 | 21 223 | 7 127 747 | |
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock |
A - Award | 36 280 | 36 280 | |||||
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 16 190 | 138 626 | 13,22 | ||||
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 2 191 | 82 269 | 2,74 | ||||
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −2 191 | 69 448 | −3,06 | ||||
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 395 | 71 639 | −3,24 | 89,57 | −214 520 | 6 416 705 | |
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 45 727 | 80 078 | 133,12 | ||||
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −45 727 | 74 034 | −38,18 | ||||
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 2 675 | 34 351 | 8,44 | ||||
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −2 675 | 119 761 | −2,18 | ||||
2016-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −47 273 | 122 436 | −27,86 | 81,87 | −3 870 241 | 10 023 835 | |
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 5 883 | 169 709 | 3,59 | ||||
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 49 600 | 163 826 | 43,42 | ||||
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 17 150 | 114 226 | 17,67 | ||||
2016-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 26 | 97 026 | 0,03 | 51,26 | 1 333 | 4 973 892 | |
2016-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 2 500 | 31 676 | 8,57 | ||||
2016-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −2 500 | 97 000 | −2,51 | ||||
2015-07-14 |
|
4 | KBIO |
KALOBIOS PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 5 000 | 5 000 | |||||
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 1 506 | 29 176 | 5,44 | ||||
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −1 506 | 99 500 | −1,49 | ||||
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 644 | 101 056 | −1,60 | 120,46 | −198 036 | 12 173 206 | |
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 1 434 | 27 670 | 5,47 | ||||
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −1 434 | 102 700 | −1,38 | ||||
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 566 | 104 134 | −1,48 | 122,78 | −192 273 | 12 785 573 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | 2 088 | 105 700 | 2,02 | 121,66 | 254 026 | 12 859 462 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 1 912 | 26 236 | 7,86 | ||||
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −1 912 | 107 788 | −1,74 | ||||
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 389 | 24 324 | 1,63 | ||||
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −389 | 109 700 | −0,35 | ||||
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 389 | 110 089 | 0,35 | 51,26 | 19 942 | 5 643 547 | |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −3 051 | 0 | −100,00 | ||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −11 000 | 0 | −100,00 | ||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −14 051 | 109 700 | −11,35 | 116,37 | −1 635 091 | 12 765 603 | |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 3 051 | 123 751 | 2,53 | 14,39 | 43 904 | 1 780 777 | |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 11 000 | 120 700 | 10,03 | 17,86 | 196 460 | 2 155 702 | |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 23 900 | 23 900 | |||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 500 | 109 700 | 10,58 | ||||
2015-02-06 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 46 | 23 935 | 0,19 | ||||
2015-02-06 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −46 | 99 200 | −0,05 | ||||
2014-12-01 |
|
4 | KBIO |
KALOBIOS PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 2 591 | 0 | −100,00 | ||||
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 27 372 | 0 | −100,00 | ||||
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −29 963 | 99 200 | −23,20 | 81,70 | −2 447 959 | 8 104 580 | |
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 2 591 | 129 163 | 2,05 | 38,59 | 99 987 | 4 984 400 | |
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 27 372 | 126 572 | 27,59 | 38,59 | 1 056 285 | 4 884 413 | |
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 35 037 | 27 372 | −457,10 | ||||
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 5 770 | 0 | −100,00 | ||||
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 4 655 | 0 | −100,00 | ||||
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −45 462 | 99 200 | −31,43 | 81,10 | −3 686 955 | 8 045 090 | |
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 35 037 | 144 662 | 31,96 | 38,59 | 1 352 078 | 5 582 507 | |
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 5 770 | 109 625 | 5,56 | 17,33 | 99 994 | 1 899 801 | |
2014-10-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 4 655 | 103 855 | 4,69 | 17,54 | 81 649 | 1 821 617 | |
2014-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 47 200 | 47 200 | |||||
2014-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 600 | 99 200 | 14,55 | ||||
2014-02-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 26 250 | 86 600 | 43,50 | ||||
2014-02-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 2 675 | 13 722 | 24,21 | ||||
2014-02-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −2 675 | 60 350 | −4,24 | ||||
2014-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 92 | 11 047 | 0,84 | ||||
2014-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −92 | 60 350 | −0,15 | ||||
2014-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 92 | 60 422 | 0,15 | 27,91 | 2 567 | 1 686 106 | |
2014-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 1 912 | 10 955 | 21,14 | ||||
2014-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −1 912 | 60 350 | −3,07 | ||||
2013-09-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −20 000 | 35 351 | −36,13 | |||
2013-09-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 62 262 | −24,31 | 73,00 | −1 460 000 | 4 545 126 |
2013-09-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 000 | 82 262 | 32,12 | 21,51 | 430 200 | 1 769 456 |
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 70 000 | 70 000 | |||||
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 000 | 62 262 | 23,87 | ||||
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −20 000 | 60 000 | −25,00 | |||
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 50 262 | −28,46 | 70,00 | −1 400 000 | 3 518 340 |
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 000 | 70 262 | 39,79 | 21,51 | 430 200 | 1 511 336 |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 088 | 50 262 | −3,99 | 65,32 | −136 388 | 3 283 114 | |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 805 | 9 043 | 9,77 | ||||
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −805 | 52 350 | −1,51 | ||||
2013-05-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −20 000 | 3 051 | −86,76 | |||
2013-05-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 53 155 | −27,34 | 67,00 | −1 340 000 | 3 561 385 |
2013-05-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 000 | 73 155 | 37,63 | 14,39 | 287 800 | 1 052 700 |
2013-05-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 805 | 53 155 | 1,54 | 23,20 | 18 680 | 1 233 462 | |
2013-04-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −20 000 | 23 051 | −46,46 | |||
2013-04-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 52 350 | −27,64 | 64,00 | −1 280 000 | 3 350 400 |
2013-04-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 000 | 72 350 | 38,20 | 14,39 | 287 800 | 1 041 116 |
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −20 000 | 50 000 | −28,57 | |||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 52 350 | −27,64 | 61,02 | −1 220 360 | 3 194 292 |
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 000 | 72 350 | 38,20 | 14,39 | 287 800 | 1 041 116 |
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 2 675 | 8 238 | 48,09 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −2 675 | 52 350 | −4,86 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 161 | 5 563 | 2,98 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −161 | 55 025 | −0,29 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 920 | 5 402 | 20,53 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −920 | 55 186 | −1,64 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 333 | 4 482 | 8,03 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −333 | 56 106 | −0,59 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 1 447 | 4 149 | 53,55 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −1 447 | 56 439 | −2,50 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 473 | 2 702 | 21,22 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −473 | 57 886 | −0,81 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 1 353 | 2 229 | 154,45 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −1 353 | 58 359 | −2,27 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | 876 | 876 | |||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −876 | 59 712 | −1,45 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −155 553 | 0 | −100,00 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −8 335 | 0 | −100,00 | ||||
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −163 888 | 60 588 | −73,01 | 22,52 | −3 691 020 | 1 364 539 | |
2013-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 163 888 | 224 476 | 270,50 | 22,00 | 3 605 536 | 4 938 472 | |
2013-02-15 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −20 379 | 80 034 | −20,30 | ||||
2013-02-15 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
P - Purchase | 161 | 100 574 | 0,16 | 21,76 | 3 503 | 2 188 490 | |
2013-01-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −19 575 | 520 313 | −3,63 | |||
2013-01-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −19 575 | 100 413 | −16,31 | 55,00 | −1 076 625 | 5 522 715 |
2013-01-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 19 575 | 119 988 | 19,49 | 17,54 | 343 346 | 2 104 590 |
2013-01-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −20 000 | 539 888 | −3,57 | |||
2013-01-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 100 413 | −16,61 | 53,00 | −1 060 000 | 5 321 889 |
2013-01-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 000 | 120 413 | 19,92 | 17,54 | 350 800 | 2 112 044 |
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −20 000 | 559 888 | −3,45 | |||
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 100 413 | −16,61 | 51,00 | −1 020 000 | 5 121 063 |
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 000 | 120 413 | 19,92 | 17,54 | 350 800 | 2 112 044 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −25 770 | 579 888 | −4,25 | |||
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −34 230 | 605 658 | −5,35 | |||
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 100 413 | −16,61 | 49,00 | −980 000 | 4 920 237 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 770 | 120 413 | −4,57 | 47,00 | −271 190 | 5 659 411 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 25 770 | 126 183 | 25,66 | 17,54 | 452 006 | 2 213 250 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −14 230 | 100 413 | −12,41 | 47,00 | −668 810 | 4 719 411 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 114 643 | −14,85 | 46,00 | −920 000 | 5 273 578 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 34 230 | 134 643 | 34,09 | 17,33 | 593 206 | 2 333 363 |
2012-10-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −20 000 | 639 888 | −3,03 | |||
2012-10-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 100 413 | −16,61 | 43,00 | −860 000 | 4 317 759 |
2012-10-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 000 | 120 413 | 19,92 | 17,33 | 346 600 | 2 086 757 |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 40 000 | 659 888 | 6,45 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | −16 000 | 100 413 | −13,74 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 920 | 84 413 | 1,10 | 19,35 | 17 798 | 1 633 054 | |
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −75 000 | 619 888 | −10,79 | 11,74 | −880 500 | 7 277 485 | |
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −16 313 | 694 888 | −2,29 | 6,13 | −99 999 | 4 259 663 | |
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −91 313 | 83 493 | −52,24 | 34,84 | −3 180 989 | 2 908 570 | |
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 75 000 | 174 806 | 75,15 | 11,74 | 880 500 | 2 052 222 | |
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 16 313 | 99 806 | 19,54 | 6,13 | 99 999 | 611 811 | |
2012-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
P - Purchase | 333 | 83 493 | 0,40 | 13,26 | 4 416 | 1 107 117 | |
2010-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2010-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 2 000 | 69 240 | 2,97 | ||||
2010-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2010-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 2 000 | 67 240 | 3,07 |